Gut microbiota can predict risk of type 2 diabetes years before it develops
· Medical Xpressby Chalmers University of Technology
edited by Sadie Harley, reviewed by Andrew Zinin
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later. This has been shown in a large Swedish study led by researchers at Chalmers University of Technology. The study is published in the journal Cell Reports Medicine.
The discovery paves the way for identifying people at risk of developing type 2 diabetes at an early stage, enabling preventive measures to be introduced.
"Our study was able to show changes in the gut microbiota several years before the disease developed. This could indicate that the composition of the microbiome plays a role in the development of diabetes, and not the other way around," says Gaël Toubon, a postdoctoral researcher in food science at Chalmers' Department of Life Sciences.
The number of adults with diabetes has more than doubled since the 1990s, according to the World Health Organization (WHO). Today, 800 million people are living with the disease, and more than 90% of cases are type 2 diabetes. Studies of the human gut microbiome, namely the bacteria and other microorganisms that live in our intestinal tract, have shown that certain changes in the gut microbiota can be seen in people with type 2 diabetes.
Common denominators among diabetes patients
Now, a comprehensive study has shown that changes in the bacteria found in the gut microbiota can be seen several years before the disease develops and could therefore predict who will go on to develop it.
As part of the EU project HealthFerm, the Chalmers researchers led a large epidemiological study involving 4,685 Swedish adults whose microbiomes were examined in stool samples. Of all the participants in the study, 383 developed diabetes after an average follow-up period of five years, and early common denominators were observed in their gut microbiota.
"We observed nine bacteria in the microbiome that are associated with the risk of developing the disease. One very interesting finding is that an individual's dietary habits appear to play a role, determining whether certain bacteria in the gut are beneficial or harmful," says Toubon.
Fiber intake is important
What surprised the researchers was that those who developed diabetes had high levels of the bacterium Akkermansia muciniphila in their gut microbiota. This bacterium is usually associated with health benefits.
"Under favorable conditions, this bacterium feeds on the fiber we get from our diet. But when our fiber intake is too low, it instead starts to break down the gut's protective mucus layer. This can lead to other bacteria coming into contact with the intestinal lining, causing inflammation and other metabolic disruptions linked to insulin resistance and type 2 diabetes," says Toubon.
One type of bacterium, Coprococcus catus, could be linked to diabetes when the bacterium was present only in very small quantities in the gut microbiota. Above a certain level, this risk was not observed.
"Research into the gut microbiota has made great strides in recent years, but the new knowledge has so far had little impact on clinical practice. In the future, these bacteria could be used as biomarkers to identify people at risk of developing type 2 diabetes. Risk factors such as obesity, heredity and blood glucose levels could be supplemented with a stool sample to better predict the risk of developing the disease and enable preventive measures to be introduced," says Toubon.
The microbiome could become a target for treatment
The Chalmers researchers' findings need to be validated in further large studies. If the role of the gut microbiota in the development of diabetes is confirmed, our microbiome could become a target for personalized preventive strategies, as the gut microbiota, unlike our genes, can be modified through lifestyle and diet.
"We cannot yet give that kind of dietary advice, but, at a general level, the study's findings support current recommendations to eat foods rich in fiber from fruit, vegetables, legumes and whole grains. Our results emphasize the importance of studying the gut microbiome together with other lifestyle factors, as together they may influence the risk of developing type 2 diabetes," says Rikard Landberg, professor at the Department of Life Sciences and lead author of the study.
Publication details
Gaël Toubon et al, Gut microbiome composition and functional potential associate with incident type 2 diabetes in 4,685 adults from a Swedish prospective cohort, Cell Reports Medicine (2026). DOI: 10.1016/j.xcrm.2026.102835
Journal information: Cell Reports Medicine
Key medical concepts
Diabetes Type 2Flora, IntestinalAkkermansia muciniphiladietary fiber intake
Clinical categories
EndocrinologyCommon illnesses & PreventionGastroenterologyNutrition & Healthy eatingHealthy living Provided by Chalmers University of Technology Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Gut microbiota can predict risk of type 2 diabetes years before it develops (2026, July 7) retrieved 7 July 2026 from https://medicalxpress.com/news/2026-07-gut-microbiota-diabetes-years.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.